These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31158779)

  • 1. Changes in tryptophan metabolism during pregnancy and postpartum periods: Potential involvement in postpartum depressive symptoms.
    Teshigawara T; Mouri A; Kubo H; Nakamura Y; Shiino T; Okada T; Morikawa M; Nabeshima T; Ozaki N; Yamamoto Y; Saito K
    J Affect Disord; 2019 Aug; 255():168-176. PubMed ID: 31158779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine pathway changes in late-life depression.
    Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
    J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal IL-6 levels and activation of the tryptophan to kynurenine pathway are associated with depressive but not anxiety symptoms across the perinatal and the post-partum period in a low-risk sample.
    Nazzari S; Molteni M; Valtorta F; Comai S; Frigerio A
    Brain Behav Immun; 2020 Oct; 89():175-183. PubMed ID: 32531426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues.
    Kohl C; Walch T; Huber R; Kemmler G; Neurauter G; Fuchs D; Sölder E; Schröcksnadel H; Sperner-Unterweger B
    J Affect Disord; 2005 Jun; 86(2-3):135-42. PubMed ID: 15935232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder.
    Sakurai M; Yamamoto Y; Kanayama N; Hasegawa M; Mouri A; Takemura M; Matsunami H; Miyauchi T; Tokura T; Kimura H; Ito M; Umemura E; Boku AS; Nagashima W; Tonoike T; Kurita K; Ozaki N; Nabeshima T; Saito K
    Sci Rep; 2020 Feb; 10(1):1961. PubMed ID: 32029791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression.
    Veen C; Myint AM; Burgerhout KM; Schwarz MJ; Schütze G; Kushner SA; Hoogendijk WJ; Drexhage HA; Bergink V
    J Affect Disord; 2016 Jan; 189():298-305. PubMed ID: 26454336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
    Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
    Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity.
    Vidal R; García-Marchena N; O'Shea E; Requena-Ocaña N; Flores-López M; Araos P; Serrano A; Suárez J; Rubio G; Rodríguez de Fonseca F; Colado MI; Pavón FJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109958. PubMed ID: 32360814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early activation of the kynurenine pathway predicts early death and long-term outcome in patients resuscitated from out-of-hospital cardiac arrest.
    Ristagno G; Latini R; Vaahersalo J; Masson S; Kurola J; Varpula T; Lucchetti J; Fracasso C; Guiso G; Montanelli A; Barlera S; Gobbi M; Tiainen M; Pettilä V; Skrifvars MB;
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between kynurenine metabolites and postpartum depression].
    Wang S; Quan C; Tan Y; Wen S; Zhang J; Duan K
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):725-731. PubMed ID: 30124207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the tryptophan-kynurenine axis in association to therapeutic response in clinically depressed patients undergoing psychiatric rehabilitation.
    Reininghaus B; Riedrich K; Dalkner N; Bengesser SA; Birner A; Platzer M; Hamm C; Gostner JM; Fuchs D; Reininghaus EZ
    Psychoneuroendocrinology; 2018 Aug; 94():25-30. PubMed ID: 29753175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of tryptophan, kynurenine, kynurenic acid, xanthurenic acid and 5-hydroxytryptamine in human plasma by LC-MS/MS and its application to acute myocardial infarction monitoring.
    Tong Q; Song J; Yang G; Fan L; Xiong W; Fang J
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the tryptophan-kynurenine pathway and painful physical symptoms in patients with major depressive disorder.
    Yun Y; Zhang Q; Zhao W; Ma T; Fan H; Bai L; Ma B; Qi S; Wang Z; An H; Yang F
    J Psychosom Res; 2022 Dec; 163():111069. PubMed ID: 36335711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine pathway changes in late-life depression with memory deficit.
    Wu Y; Mai N; Zhong X; Wen Y; Zhou Y; Li H; Shang D; Hu L; Chen X; Chen B; Zhang M; Ning Y
    Psychiatry Res; 2018 Nov; 269():45-49. PubMed ID: 30145300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
    Raison CL; Dantzer R; Kelley KW; Lawson MA; Woolwine BJ; Vogt G; Spivey JR; Saito K; Miller AH
    Mol Psychiatry; 2010 Apr; 15(4):393-403. PubMed ID: 19918244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.